DEA revokes a major drug distributor’s license over opioid crisis failures

The DEA revokes Morris & Dickson Co.’s license to sell painkillers, citing a failure to flag suspicious orders during the opioid crisis.

License removal: The distributor, which generates $4 billion a year in revenue, potentially faces the end of the business after the DEA’s decision.
* The order becomes effective in 90 days, allowing more time to negotiate a settlement.

What they found: Morris & Dickson failed to accept full responsibility for their actions, which included shipping 12,000 unusually large orders of opioids between 2014 and 2018.
* The company only filed three suspicious order reports with the DEA during this time.

Company response: Morris & Dickson has invested millions to revamp its compliance systems and expressed hope for a settlement.
* In a statement, the company said it is ~~”grateful to the DEA administrator for delaying the effective date of the order.”~~

By the numbers: The nation’s fourth-largest wholesale drug distributor serves pharmacies and hospitals in 29 states and has nearly 600 employees.

View original article on NPR

This summary was created by an AI system. The use of this summary is subject to our Terms of Service.

Contact us about this post






Leave a Reply

Your email address will not be published. Required fields are marked *